Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells (Q39895746)

15 September 2017

Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells (English)

1 reference

15 September 2017

1 reference

6

Annamaria Colao

1 reference

15 September 2017

7

Gaetano Lombardi

1 reference

15 September 2017

3

Wouter W de Herder

1 reference

15 September 2017

Giovanni Vitale

1

1 reference

15 September 2017

Peter M van Koetsveld

2

1 reference

15 September 2017

Katy van der Wansem

4

1 reference

15 September 2017

Joop A M J L Janssen

5

1 reference

15 September 2017

Steven W J Lamberts

8

1 reference

15 September 2017

Leo J Hofland

9

1 reference

15 September 2017

13 January 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

15 September 2017

1 reference

15 September 2017

296

1 reference

15 September 2017

3

1 reference

15 September 2017

E559-66

1 reference

Alpha-interferon and its effects on signal transduction pathways

15 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Double-stranded RNA decreases IGF-I gene expression in a protein kinase R-dependent, but type I interferon-independent, mechanism in C6 rat glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Molecular interactions of the IGF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Percoll density gradient centrifugation of rat pituitary tumor cells: a study of functional heterogeneity within and between tumors with respect to growth rates, prolactin production and responsiveness to the somatostatin analog SMS 201-995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

In vitro comparative study of the antitumor effects of human interferon-alpha, beta and gamma on the growth and invasive potential of human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

The insulin-like growth factor system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Pharmacokinetics and pharmacodynamics of PEGylated IFN-beta 1a following subcutaneous administration in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Interferons, interferon-like cytokines, and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Signaling pathways activated by interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Insulin-like growth factor expression in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

Regulation of cyclin D1 expression by autocrine IGF-I in human BON neuroendocrine tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90770.2008

10.1152/AJPENDO.90770.2008

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference